-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$20.3394.17% Upside
Benitec Biopharma Inc. Frequently Asked Questions
-
What analysts cover Benitec Biopharma Inc.?
Benitec Biopharma Inc. has been rated by research analysts at JMP Securities, Leerink Partners, Piper Sandler in the past 90 days.